Skip to main content
Top

Acta Diabetologica

Issue 2/2021

Content (17 Articles)

Atrial Fibrillation Review Article

Left atrial function in diabetes: does it help?

Marijana Tadic, Cesare Cuspidi

Type 1 Diabetes Original Article

Type 1 diabetes outcomes of children born in Israel of Eritrean asylum seekers

Erella Elkon-Tamir, Yael Lebenthal, Irina Laurian, Anna Dorfman, Efrat Chorna, Hagar Interator, Galit Israeli, Gil Rosen, Ori Eyal, Asaf Oren, Avivit Brener

Hypoglycemia Original Article

Predictions of diabetes complications and mortality using hba1c variability: a 10-year observational cohort study

Sharen Lee, Tong Liu, Jiandong Zhou, Qingpeng Zhang, Wing Tak Wong, Gary Tse

Open Access Original Article

Bacterial strains colonizing the sensor electrodes of a continuous glucose monitoring system in children with diabetes

Sebastian Seget, Ewa Rusak, Mirosław Partyka, Ewa Samulska, Aleksandra Pyziak-Skupień, Halla Kamińska, Eliza Skała-Zamorowska, Przemysława Jarosz-Chobot

Open Access Intense Pulsed Light Original Article

Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression

Inês P. Marques, Maria H. Madeira, Ana L. Messias, António C.-V. Martinho, Torcato Santos, David C. Sousa, João Figueira, José Cunha-Vaz

Open Access Insulins Original Article

One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes

Goran Petrovski, Fawziya Al Khalaf, Judith Campbell, Fareeda Umer, Douha Almajaly, Manar Hamdan, Khalid Hussain

Losartan Original Article

Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial

Flávio D. Fuchs, Luiz C. N. Scala, José F. Vilela-Martin, Paul K. Whelton, Carlos E. Poli-de-Figueiredo, Ricardo Pereira E Silva, Miguel Gus, Luiz A. Bortolotto, Fernanda M. Consolim-Colombo, Rosane P. Schlatter, José E. Cesarino, Iran Castro, José A. Figueiredo Neto, Hilton Chaves, André A. Steffens, João G. Alves, Andréa A. Brandão, Marcos R. de Sousa, Paulo C. Jardim, Leila B. Moreira, Roberto S. Franco, Marco M. Gomes, Abrahão Afiune Neto, Felipe C. Fuchs, Dario C. Sobral Filho, Antônio C. Nóbrega, Fernando Nobre, Otávio Berwanger, Sandra C. Fuchs

Open Access Diabetic Retinopathy Original Article

Elevated plasma trimethylamine-N-oxide levels are associated with diabetic retinopathy

Weiming Liu, Chunmin Wang, Yu Xia, Wei Xia, Gaoqin Liu, Chi Ren, Yu Gu, Xin Li, Peirong Lu

Open Access Insulins Original Article

Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England

Joshi Prabhu Navis, Lalantha Leelarathna, Womba Mubita, Andrea Urwin, Martin K. Rutter, Jonathan Schofield, Hood Thabit

Insulins Short Communication

Increased fecal indole concentration in women with gestational diabetes: a pilot study

Marija Trajkova, Katja Molan, Maja Zugan, Jerneja Ambrožič Avguštin, Marjanca Starčič Erjavec, Darja Žgur Bertok, Draženka Pongrac Barlovič

Sitagliptin Letter to the Editor

Use of DPP-4 inhibitors in patients with COVID-19

Chia Siang Kow, Syed Shahzad Hasan

Sitagliptin Letter to the Editor

Reply to letter to the editor regarding “Use of DPP-4 inhibitors in patients with COVID-19”

Sebastiano Bruno Solerte, Francesca D’Addio, Paolo Fiorina

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine